{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.3170","meta":{"versionId":"5","lastUpdated":"2020-08-18T10:21:27.000-04:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>COVID19 ICD10CM Value Set for Immune System Disorders</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <code>http://hl7.org/fhir/sid/icd-10-cm</code>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>D80</td>\n              <td>Immunodeficiency with predominantly antibody defects</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.0</td>\n              <td>Hereditary hypogammaglobulinemia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.1</td>\n              <td>Nonfamilial hypogammaglobulinemia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.2</td>\n              <td>Selective deficiency of immunoglobulin A [IgA]</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.3</td>\n              <td>Selective deficiency of immunoglobulin G [IgG] subclasses</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.4</td>\n              <td>Selective deficiency of immunoglobulin M [IgM]</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.5</td>\n              <td>Immunodeficiency with increased immunoglobulin M [IgM]</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.6</td>\n              <td>Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.7</td>\n              <td>Transient hypogammaglobulinemia of infancy</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.8</td>\n              <td>Other immunodeficiencies with predominantly antibody defects</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.9</td>\n              <td>Immunodeficiency with predominantly antibody defects, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81</td>\n              <td>Combined immunodeficiencies</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.0</td>\n              <td>Severe combined immunodeficiency [SCID] with reticular dysgenesis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.1</td>\n              <td>Severe combined immunodeficiency [SCID] with low T- and B-cell numbers</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.2</td>\n              <td>Severe combined immunodeficiency [SCID] with low or normal B-cell numbers</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.3</td>\n              <td>Adenosine deaminase [ADA] deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.30</td>\n              <td>Adenosine deaminase deficiency, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.31</td>\n              <td>Severe combined immunodeficiency due to adenosine deaminase deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.32</td>\n              <td>Adenosine deaminase 2 deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.39</td>\n              <td>Other adenosine deaminase deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.4</td>\n              <td>Nezelof's syndrome</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.5</td>\n              <td>Purine nucleoside phosphorylase [PNP] deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.6</td>\n              <td>Major histocompatibility complex class I deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.7</td>\n              <td>Major histocompatibility complex class II deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.8</td>\n              <td>Other combined immunodeficiencies</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.81</td>\n              <td>Biotin-dependent carboxylase deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.810</td>\n              <td>Biotinidase deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.818</td>\n              <td>Other biotin-dependent carboxylase deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.819</td>\n              <td>Biotin-dependent carboxylase deficiency, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.89</td>\n              <td>Other combined immunodeficiencies</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.9</td>\n              <td>Combined immunodeficiency, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D82</td>\n              <td>Immunodeficiency associated with other major defects</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D82.0</td>\n              <td>Wiskott-Aldrich syndrome</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D82.1</td>\n              <td>Di George's syndrome</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D82.2</td>\n              <td>Immunodeficiency with short-limbed stature</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D82.3</td>\n              <td>Immunodeficiency following hereditary defective response to Epstein-Barr virus</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D82.4</td>\n              <td>Hyperimmunoglobulin E [IgE] syndrome</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D82.8</td>\n              <td>Immunodeficiency associated with other specified major defects</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D82.9</td>\n              <td>Immunodeficiency associated with major defect, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D83</td>\n              <td>Common variable immunodeficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D83.0</td>\n              <td>Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D83.1</td>\n              <td>Common variable immunodeficiency with predominant immunoregulatory T-cell disorders</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D83.2</td>\n              <td>Common variable immunodeficiency with autoantibodies to B- or T-cells</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D83.8</td>\n              <td>Other common variable immunodeficiencies</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D83.9</td>\n              <td>Common variable immunodeficiency, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D84</td>\n              <td>Other immunodeficiencies</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D84.0</td>\n              <td>Lymphocyte function antigen-1 [LFA-1] defect</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D84.1</td>\n              <td>Defects in the complement system</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D84.8</td>\n              <td>Other specified immunodeficiencies</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D84.9</td>\n              <td>Immunodeficiency, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89</td>\n              <td>Other disorders involving the immune mechanism, not elsewhere classified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.0</td>\n              <td>Polyclonal hypergammaglobulinemia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.1</td>\n              <td>Cryoglobulinemia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.2</td>\n              <td>Hypergammaglobulinemia, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.3</td>\n              <td>Immune reconstitution syndrome</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.4</td>\n              <td>Mast cell activation syndrome and related disorders</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.40</td>\n              <td>Mast cell activation, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.41</td>\n              <td>Monoclonal mast cell activation syndrome</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.42</td>\n              <td>Idiopathic mast cell activation syndrome</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.43</td>\n              <td>Secondary mast cell activation</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.49</td>\n              <td>Other mast cell activation disorder</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.8</td>\n              <td>Other specified disorders involving the immune mechanism, not elsewhere classified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.81</td>\n              <td>Graft-versus-host disease</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.810</td>\n              <td>Acute graft-versus-host disease</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.811</td>\n              <td>Chronic graft-versus-host disease</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.812</td>\n              <td>Acute on chronic graft-versus-host disease</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.813</td>\n              <td>Graft-versus-host disease, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.82</td>\n              <td>Autoimmune lymphoproliferative syndrome [ALPS]</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.89</td>\n              <td>Other specified disorders involving the immune mechanism, not elsewhere classified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D89.9</td>\n              <td>Disorder involving the immune mechanism, unspecified</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.3170","version":"20200715","name":"COVID19 ICD10CM Value Set for Immune System Disorders","status":"active","date":"2020-07-15T01:00:26-04:00","publisher":"Clinical Architecture","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","concept":[{"code":"D80","display":"Immunodeficiency with predominantly antibody defects"},{"code":"D80.0","display":"Hereditary hypogammaglobulinemia"},{"code":"D80.1","display":"Nonfamilial hypogammaglobulinemia"},{"code":"D80.2","display":"Selective deficiency of immunoglobulin A [IgA]"},{"code":"D80.3","display":"Selective deficiency of immunoglobulin G [IgG] subclasses"},{"code":"D80.4","display":"Selective deficiency of immunoglobulin M [IgM]"},{"code":"D80.5","display":"Immunodeficiency with increased immunoglobulin M [IgM]"},{"code":"D80.6","display":"Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia"},{"code":"D80.7","display":"Transient hypogammaglobulinemia of infancy"},{"code":"D80.8","display":"Other immunodeficiencies with predominantly antibody defects"},{"code":"D80.9","display":"Immunodeficiency with predominantly antibody defects, unspecified"},{"code":"D81","display":"Combined immunodeficiencies"},{"code":"D81.0","display":"Severe combined immunodeficiency [SCID] with reticular dysgenesis"},{"code":"D81.1","display":"Severe combined immunodeficiency [SCID] with low T- and B-cell numbers"},{"code":"D81.2","display":"Severe combined immunodeficiency [SCID] with low or normal B-cell numbers"},{"code":"D81.3","display":"Adenosine deaminase [ADA] deficiency"},{"code":"D81.30","display":"Adenosine deaminase deficiency, unspecified"},{"code":"D81.31","display":"Severe combined immunodeficiency due to adenosine deaminase deficiency"},{"code":"D81.32","display":"Adenosine deaminase 2 deficiency"},{"code":"D81.39","display":"Other adenosine deaminase deficiency"},{"code":"D81.4","display":"Nezelof's syndrome"},{"code":"D81.5","display":"Purine nucleoside phosphorylase [PNP] deficiency"},{"code":"D81.6","display":"Major histocompatibility complex class I deficiency"},{"code":"D81.7","display":"Major histocompatibility complex class II deficiency"},{"code":"D81.8","display":"Other combined immunodeficiencies"},{"code":"D81.81","display":"Biotin-dependent carboxylase deficiency"},{"code":"D81.810","display":"Biotinidase deficiency"},{"code":"D81.818","display":"Other biotin-dependent carboxylase deficiency"},{"code":"D81.819","display":"Biotin-dependent carboxylase deficiency, unspecified"},{"code":"D81.89","display":"Other combined immunodeficiencies"},{"code":"D81.9","display":"Combined immunodeficiency, unspecified"},{"code":"D82","display":"Immunodeficiency associated with other major defects"},{"code":"D82.0","display":"Wiskott-Aldrich syndrome"},{"code":"D82.1","display":"Di George's syndrome"},{"code":"D82.2","display":"Immunodeficiency with short-limbed stature"},{"code":"D82.3","display":"Immunodeficiency following hereditary defective response to Epstein-Barr virus"},{"code":"D82.4","display":"Hyperimmunoglobulin E [IgE] syndrome"},{"code":"D82.8","display":"Immunodeficiency associated with other specified major defects"},{"code":"D82.9","display":"Immunodeficiency associated with major defect, unspecified"},{"code":"D83","display":"Common variable immunodeficiency"},{"code":"D83.0","display":"Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function"},{"code":"D83.1","display":"Common variable immunodeficiency with predominant immunoregulatory T-cell disorders"},{"code":"D83.2","display":"Common variable immunodeficiency with autoantibodies to B- or T-cells"},{"code":"D83.8","display":"Other common variable immunodeficiencies"},{"code":"D83.9","display":"Common variable immunodeficiency, unspecified"},{"code":"D84","display":"Other immunodeficiencies"},{"code":"D84.0","display":"Lymphocyte function antigen-1 [LFA-1] defect"},{"code":"D84.1","display":"Defects in the complement system"},{"code":"D84.8","display":"Other specified immunodeficiencies"},{"code":"D84.9","display":"Immunodeficiency, unspecified"},{"code":"D89","display":"Other disorders involving the immune mechanism, not elsewhere classified"},{"code":"D89.0","display":"Polyclonal hypergammaglobulinemia"},{"code":"D89.1","display":"Cryoglobulinemia"},{"code":"D89.2","display":"Hypergammaglobulinemia, unspecified"},{"code":"D89.3","display":"Immune reconstitution syndrome"},{"code":"D89.4","display":"Mast cell activation syndrome and related disorders"},{"code":"D89.40","display":"Mast cell activation, unspecified"},{"code":"D89.41","display":"Monoclonal mast cell activation syndrome"},{"code":"D89.42","display":"Idiopathic mast cell activation syndrome"},{"code":"D89.43","display":"Secondary mast cell activation"},{"code":"D89.49","display":"Other mast cell activation disorder"},{"code":"D89.8","display":"Other specified disorders involving the immune mechanism, not elsewhere classified"},{"code":"D89.81","display":"Graft-versus-host disease"},{"code":"D89.810","display":"Acute graft-versus-host disease"},{"code":"D89.811","display":"Chronic graft-versus-host disease"},{"code":"D89.812","display":"Acute on chronic graft-versus-host disease"},{"code":"D89.813","display":"Graft-versus-host disease, unspecified"},{"code":"D89.82","display":"Autoimmune lymphoproliferative syndrome [ALPS]"},{"code":"D89.89","display":"Other specified disorders involving the immune mechanism, not elsewhere classified"},{"code":"D89.9","display":"Disorder involving the immune mechanism, unspecified"}]}]}}